Proficiency Test PD-L1 Expression in Squamous Cell Carcinomas of the Head and Neck (HNSCC)

被引：0
|
作者：
Joehrens, Korinna [1 ,9 ]
Baretton, Gustavo [1 ]
Schildhaus, Hans-Ulrich [2 ]
Agaimy, Abbas [3 ]
Scheel, Andreas [4 ]
Schwammborn, Kristina [5 ]
Laenger, Florian [6 ]
Tiemann, Markus [7 ]
Dietel, Manfred [8 ,9 ]
机构：
[1] Tech Univ Dresden, Carl Gustav Carus Univ Klinikum, Inst Pathol, Fetscherstr 74, D-01307 Dresden, Germany
[2] Univ Klinikum Essen, Inst Pathol, Essen, Germany
[3] Univ Klinikum Erlangen, Pathol Inst, Erlangen, Germany
[4] Univ Klinikum Koln, Inst Pathol, Cologne, Germany
[5] Tech Univ Munich, Inst Pathol, Munich, Germany
[6] Hannover Med Sch, Inst Pathol, Hannover, Germany
[7] Inst Hamatopathol Hamburg, Hamburg, Germany
[8] Univ Klinikum Charite, Inst Pathol, Campus Mitte,Charitepl 1, Berlin, Germany
[9] QuIP GmbH, Berlin, Germany
来源：
PATHOLOGE | 2021年 / 42卷 / 03期
关键词：
D O I：
10.1007/s00292-021-00931-y
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：352 / 353
页数：2
相关论文
共 50 条
  • [31] Distinctions in Tumor Microenvironment Between PD-L1 Positive versus Negative Head and Neck Squamous Cell Carcinoma (HNSCC)
    Saini, Kamal S.
    Ko, Heidi C.
    Wallen, Zachary D.
    Green, Michelle F.
    Strickland, Kyle C.
    Previs, Rebecca A.
    Zhang, Shengle
    Conroy, Jeffrey
    Jensen, Taylor J.
    Caveney, Brian J.
    Eisenberg, Marcia
    Vidal, Laura
    Severson, Eric A.
    Ramkissoon, Shakti
    RADIOTHERAPY AND ONCOLOGY, 2024, 192 : S20 - S22
  • [32] PD-L1 expression in the microenvironment and the response to checkpoint inhibitors in head and neck squamous cell carcinoma
    Evrard, D.
    Hourseau, M.
    Couvelard, A.
    Paradis, V.
    Gauthier, H.
    Raymond, E.
    Halimi, C.
    Barry, B.
    Faivre, S.
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [33] Turning the tide: Clinical utility of PD-L1 expression in squamous cell carcinoma of the head and neck
    De Meulenaere, Astrid
    Vermassen, Tijl
    Aspeslagh, Sandrine
    Huvenne, Wouter
    Van Dorpe, Jo
    Ferdinande, Liesbeth
    Rottey, Sylvie
    ORAL ONCOLOGY, 2017, 70 : 34 - 42
  • [34] Significance of PD-L1 expression in pulmonary metastases from head and neck squamous cell carcinoma
    Okada, Satoru
    Itoh, Kyoko
    Ishihara, Shunta
    Shimada, Junichi
    Kato, Daishiro
    Tsunezuka, Hiroaki
    Miyata, Naoko
    Hirano, Shigeru
    Teramukai, Satoshi
    Inoue, Masayoshi
    SURGICAL ONCOLOGY-OXFORD, 2018, 27 (02): : 259 - 265
  • [35] PD-L1 Expression is Increased in Metastasizing Squamous Cell Carcinomas and Their Metastases
    Garcia-Diez, Irene
    Hernandez-Ruiz, Eugenia
    Andrades, Evelyn
    Gimeno, Javier
    Ferrandiz-Pulido, Carla
    Yebenes, Mireia
    Garcia-Patos, Vicenc
    Pujol, Ramon M.
    Hernandez-Munoz, Inmaculada
    Toll, Agusti
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2018, 40 (09) : 647 - 654
  • [36] PD-L1 Expression and clinical Correlation in cutaneous Squamous Cell Carcinomas
    Schaper, K.
    Koether, B.
    Hesse, K.
    Satzger, I
    Gutzmer, R.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 : 9 - 9
  • [37] The current advances and future directions of PD-1/PD-L1 blockade in head and neck squamous cell carcinoma (HNSCC) in the era of immunotherapy
    Chen, Yunhao
    Ding, Xingchen
    Bai, Xinbin
    Zhou, Zihan
    Liu, Yu
    Zhang, Xianbin
    Yu, Jinming
    Hu, Man
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 120
  • [38] The role of the PD-L1: PD-1 pathway in squamous cell carcinoma of the head and neck
    Zandberg, Dan P.
    Strome, Scott E.
    ORAL ONCOLOGY, 2014, 50 (07) : 627 - 632
  • [39] Circulating tumour cell PD-L1 test for head and neck cancers
    Kulasinghe, Arutha
    Kenny, Liz
    Punyadeera, Chamindie
    ORAL ONCOLOGY, 2017, 75 : 6 - 7
  • [40] Targeting PD-L1 sensitizes head and neck squamous cell carcinoma to cisplatin
    Qiao, Peter
    Lajud, Shayanne A.
    Nagda, Danish A.
    Tanaka, Nobuaki
    Civantos, Alyssa
    O'Malley, Bert W.
    Li, Daqing
    CANCER RESEARCH, 2014, 74 (19)
12345